Evidence method
Level · gp.fundamentals.debt_to_revenue
115.54% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ICCC · Jun 30, 2026
IMMUCELL CORP /DE/. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001437749-26-027668General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
10.21% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
42.01% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
11.50% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
126.33% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
33.92% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
26.93% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.67% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
3.34% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Sep 30, 20220/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20250/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20267/9 normalizedLevel 3Jun 30, 20267/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 84.02%
- Current
- 115.54%
- Delta
- 31.52%
- Previous
- 1.71%
- Current
- 10.21%
- Delta
- 8.50%
- Previous
- 34.50%
- Current
- 42.01%
- Delta
- 7.51%
- Previous
- 28.39%
- Current
- 11.50%
- Delta
- -16.89%
- Previous
- 83.75%
- Current
- 126.33%
- Delta
- 42.59%
- Previous
- 44.97%
- Current
- 33.92%
- Delta
- -11.05%
- Previous
- 19.01%
- Current
- 26.93%
- Delta
- 7.91%
- Previous
- 3.07%
- Current
- 1.67%
- Delta
- -1.40%
- Previous
- 1.33%
- Current
- 3.34%
- Delta
- 2.01%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · In Vitro & In Vivo Diagnostic Substances peers →Transitioned To · ICCC Fundamental State →Transitioned To · ICCC BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · ICCC CAPEX_INTENSITY_INCREASED →Transitioned To · ICCC CASH_GENERATION_INCREASED →Transitioned To · ICCC GROWTH_DECREASED →Transitioned To · ICCC INVENTORY_PRESSURE_INCREASED →Transitioned To · ICCC MARGIN_DECREASED →Transitioned To · ICCC PROFITABILITY_INCREASED →Transitioned To · ICCC R_AND_D_INTENSITY_DECREASED →Transitioned To · ICCC SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.